Fate therapeutics to webcast conference call reporting fourth quarter and full year 2021 financial results

San diego, feb. 16, 2022 (globe newswire) -- fate therapeutics, inc. (the “company” or “fate therapeutics”) (nasdaq: fate), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, today announced that the company will host a conference call and live audio webcast on monday, february 28, 2022 at 5:00 pm et to report its fourth quarter and full year 2021 financial results and provide a corporate update.
FATE Ratings Summary
FATE Quant Ranking